Metabolomic Approaches for the Identification of Non-Invasive Biomarkers in Dengue Infection: A Systematic Review
Authors:
- Janni Gómez-MontoyaJGJanni Gómez-Montoya
- Daniela Martínez-BerríoDMDaniela Martínez-Berrío
- Nicole Espinosa-BernalNENicole Espinosa-Bernal
- Leidy Hurtado-GómezLHLeidy Hurtado-Gómez
- Yirys Díaz-OlmosYDYirys Díaz-Olmos
- Elkin Navarro-QuirozElkin Navarro-Quiroz
- Antonio Acosta HoyosAHAntonio Acosta Hoyos
- Lisandro Pacheco-LugoLPLisandro Pacheco-Lugo
Preprint
- 31 August 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Dengue is a major mosquito-borne viral disease whose rapid progression from self-limiting fever to hemorrhagic or shock syndrome (DHF/DSS) remains difficult to predict using conventional clinical markers. Metabolomics offers a promising avenue for identifying non-invasive biomarkers of infection and severity, but the evidence remains scattered across biofluids and analytical platforms. This systematic review synthesized human metabolomic studies of dengue infection to characterize the biofluids, techniques, and metabolic signatures reported to date. Following PRISMA 2020 guidelines, PubMed, ScienceDirect, and Web of Science were searched for studies applying NMR- or MS-based metabolomics to human dengue samples, screened against PECO criteria requiring a healthy-control or severity comparison group. Of 780 records identified, 17 studies met all eligibility criteria. Most studies (14/17) analyzed blood-derived matrices (serum, plasma, or whole blood), while three analyzed urine; no eligible study examined feces, saliva, tears, sweat, or cerebrospinal fluid. Across studies, three convergent patterns emerged with increasing disease severity: depletion of serotonin and related tryptophan-pathway metabolites, disturbance of glycerophospholipid and lysophospholipid classes, and elevation of markers of hepatic and lipid-metabolic stress (bile acids, VLDL/LDL changes, acylcarnitines). Serotonin combined with IFN-γ achieved the strongest discriminatory performance reported (AUC = 0.92) for progression to DHF, while urinary alkanes and betaine emerged as candidate non-invasive markers linked to infection status and comorbidities such as diabetes. These findings highlight a persistent reliance on blood-based sampling and a near-total absence of studies exploring alternative, more accessible biofluids, representing a clear gap for future non-invasive biomarker research in dengue.Keywords
All Related Versions
This publication has 21 references indexed in Scilit:
- Early biomarkers for prediction of severe manifestations of dengue fever: a systematic review and a meta-analysisScientific Reports, 2023
- Integrated clinical and metabolomic analysis of dengue infection shows molecular signatures associated with host-pathogen interaction in different phases of the diseaseMetabolomics, 2023
- Serum fatty acids and progression from dengue fever to dengue haemorrhagic fever/dengue shock syndromeBritish Journal of Nutrition, 2018
- The role of lipids in the inception, maintenance and complications of dengue virus infectionScientific Reports, 2018
- Phospholipidomic identification of potential serum biomarkers in dengue fever, hepatitis B and hepatitis C using liquid chromatography-electrospray ionization-tandem mass spectrometryJournal of Chromatography B, 2016
- Metabolomics for characterization of gender differences in patients infected with dengue virusAsian Pacific Journal of Tropical Medicine, 2015
- The Strengths and Weaknesses of NMR Spectroscopy and Mass Spectrometry with Particular Focus on Metabolomics Research2015
- DengueThe Lancet, 2015
- Profiling of esterified fatty acids as biomarkers in the blood of dengue fever patients using a microliter‐scale extraction followed by gas chromatography and mass spectrometryJournal of Separation Science, 2014
- The global distribution and burden of dengueNature, 2013